Å·²©¼¯ÍÅѧԺ | ¡°µ°°×Öû»·¨¡±½áºÏICP-MS¼ì²âÄòÒºÖÐÒøÀë×ÓŨ¶È
·¢²¼Ê±¼ä£º
2020-08-07
À´Ô´£º
ͻ񻣼
ͨ¹ý“µ°°×Öû»·¨”£¬¿ÉÒÔ·Ö²½ÊµÏÖÄòÒºÖÐÒøÀë×ӵĽâ¾ÛºÍ½âÎü¸½£¬ÓÐЧ½â¾öÒøÀë×Ó·ÇÌØÒìÐÔÎü¸½ºÍÑÏÖØ²ÐÁôµÄÄÑÌ⣬Ìá¸ßÉúÎï»ùÖÊÖнðÊôÀë×ÓµÄÌáȡЧÂÊ£¬¸ÄÉÆICP-MSÔÚ½ðÊôÀë×ÓÅ·²©¼¯ÍŹÙÍøÎïÖеÄÅ·²©¼¯ÍŹÙÍø´ú¶¯Á¦Ñ§¼ì²âÓ¦Óá£
ǰ´¦ÀíÊǼì²â½ðÊôÀë×ӵĹؼü
ÒøÀë×ÓÅ·²©¼¯ÍŹÙÍøÎïµÄɱ¾ú»úÀí£¬ÊÇͨ¹ýÓÎÀëµÄAg+½áºÏϸ°ûµÈ΢ÉúÎïÖе°°×ÖʵÄ×ÔÓÉÊè»ù£¨¿ÉÄæ½áºÏ£©£¬¸Ä±äµ°°×±íÃæµçºÉ£¬Ê¹µ°°×ÖʱäÐÔ¶øÄý¹Ì£¬ÆÆ»µÏ¸°ûºÏ³Éø»îÐÔ£¬Ï¸°ûÒòɥʧ·ÖÁÑÔöÖ³ÄÜÁ¦¶øËÀÍö¡£
´ó²¿·ÖÒøÀë×ÓÅ·²©¼¯ÍŹÙÍøÎïµÄʹÓÃŨ¶ÈÇ÷½üÓÚºÛÁ¿£¨µÍÖÁμg/ml»òng/ml£©£¬ÎÞÒɶÔÒøÀë×ÓŨ¶ÈµÄ¼ì²âÁéÃô¶ÈºÍ׼ȷÐÔÌá³öÁËÌôÕ½¡£µç¸ÐñîºÏµÈÀë×ÓÌåÖÊÆ×·¨£¨ICP-MS£©ÊǼì²âÒøÀë×ӵȽðÊôÀë×ÓµÄÊ×Ñ¡£¬³£Ó¦ÓÃÓÚÍÁÈÀ¡¢»¯×±Æ·¡¢Ë®Ì塢ũ×÷ÎʳƷµÈ»ùÌå¸ÉÈŽϵ͵ĻùÖÊÖУ¬ÈçºÎÓÐЧµÄÅųý»ò½µµÍÄòÒº¡¢Ñª½¬µÈÉúÎï»ùÖÊÖеÄÒøÀë×Ó¼ì²â¸ÉÈÅ£¬ÊÇ¿ª·¢Ïà¹Ø¼ì²â·½·¨±ØÐë½â¾öµÄÎÊÌâ¡£
ÒÔÄòÒºÕâÀàË®ÈÜÒº»ùÖÊÀ´Ëµ£¬Ëüº¬ÓдóÁ¿Ë®·Ö£¬ÉÙÁ¿ÎÞ»úÑΡ¢ÄòËØ¡¢ÄòËáµÈ£¬ÒÔ¼°º¬Á¿ºÜµÍµÄµ°°×ÖÊºÍÆÏÌÑÌÇ¡£ÔÚ¼îÐÔÄòÒºÖУ¬´øÕýµçºÉµÄÒøÀë×Ó¼«Ò×Îü¸½ÔÚ±íÃæ´ø¸ºµçºÉµÄÈÝÆ÷ÉÏ£¨Èç²£Á§¡¢¾Û±ûÏ©»ò¾Û±½ÒÒÏ©£©£¬ÆÕͨ³¬Éù´¦ÀíºÍ΢²¨Ïû½âÄÑÒÔÓÐЧ½â³ýÎü¸½¡£´ËÍ⣬ÓÉÓÚµ¨ÖÅÅйÊÇÏû³ýÒøµÄÖ÷Òª·½Ê½£¬¶ø²»ÊǾÉöÅÅй£¬ÈçÐè´ÓÄòÒºÖмì²âµ½Òø£¬ÐèҪǰ´¦Àí·½·¨·Ç³£¸ßЧµÄ¸»¼¯¼«µÍŨ¶ÈÒøÀë×Ó¡£
µ±Ç°µÄÏû½â·¨µÈǰ´¦Àí·½·¨Ö÷Òª¾ÖÏÞÔÚÓÚ£º
¢Ù´¦Àí·½·¨¼òµ¥£¬¶à²ÉÓÃÏõËáÒ»²½Ö±½ÓÏ¡ÊÍ£¬»òÔö¼Ó¹ÌÏàÝÍÈ¡£¬µ«ÊÇÒøÀë×Ó¼«Ò×Îü¸½ÔڹܱڻòÕßÝÍÈ¡ÖùÉÏ£¬½âÎü¸½Ð§¹û²î£»
¢Ú½âÎü¸½µÄÒøÀë×ÓÔÚ¸»¼¯¹ý³ÌÖУ¬Ò×Ôٴη¢ÉúÎü¸½¶øËðʧ£¬´Î¶ø²úÉú²ÐÁôЧӦ£¬ÄÑÒÔÊÊÓÃÓÚÒøÀë×ÓÅ·²©¼¯ÍŹÙÍøÎïµÄ¶¨Á¿Ñо¿¡£Òò´Ë£¬¿ª·¢Ò»ÖָĽøµÄÉúÎï»ùÖÊÖÐÒøÀë×Ó¸»¼¯·½·¨¾ßÓÐÏÖʵÒâÒå¡£
“µ°°×Öû»·¨”ǰ´¦Àí·½·¨ÔÀí
»ùÓÚÉÏÊöµÄÄòÒºÖÐÒøÀë×Ó¸»¼¯ÄÑÌ⣬ŷ²©¼¯ÍÅÉúÎï·ÖÎö²âÊÔÖÐÐļ¼ÊõÍŶӿª·¢ÁË“µ°°×Öû»·¨”ǰ´¦Àí·½·¨£¬ÀûÓõ°°×-ÒøÀë×ÓòüºÏÎïµÄ¾ÛºÏÄÜÁ¦Ç¿ÓÚÒøÀë×ÓÓë¹Ü±ÚµÄ·ÇÌØÒìÐÔÎü¸½ÄÜÁ¦£¬Í¬Ê±£¬¸ÃòüºÏÎïÓÖ¿ÉÒÔͨ¹ýpHµÄ¸Ä±äʵÏ־ۺϺͽâ¾Û£¬ÊµÏÖ¶ÔÉúÎï»ùÖÊÖÐÒøÀë×Ó½øÐиßЧ¸»¼¯£¬Ïà¹ØÔÀí¼ûÏÂͼ¡£ÊµÊ©¹ý³Ì°üÀ¨£º
1£©ÄòÒºÑù±¾ÓëÉÙÁ¿Ï¡ÏõËá¾Ò»¶¨±ÈÀý»ìºÏ£¬¸Ä±äÄòÒºµÄpHֵΪÈõ¼îÐÔ»òÖÐÐÔ£¬½âÎü¸½ÈÝÆ÷¹Ü±ÚÉϵĴ󲿷ÖÒøÀë×Ó£»
2£©¼ÓÈëÒ»¶¨Á¿µ°°×ÈÜÒº£¬ÀûÓõ°°×ÓëÒøÀë×ӵȽðÊôÎïÖÊÔÚÈõ¼îÐÔ»òÖÐÐÔ»·¾³ÏµÄÎü¸½×÷ÓÃÁ¦£¬Ô¶´óÓÚÈÝÆ÷¹Ü±ÚÓëÒøÀë×ÓÎü¸½×÷ÓÃÁ¦µÄÌØÕ÷£¬1¸öµ°°×·Ö×ӿɽáºÏn¸öÒøÀë×Ó£¬Öû»½áºÏÈÝÆ÷¹Ü±ÚÉÏ¡¢²¿·ÖÓÎÀëÔÚÈÜÒºÖеÄÒøÀë×Ó£¬Ðγɵ°°×-ÒøÀë×ÓòüºÏÎ
3£©¼ÓÈëÊʵ±±¶ÂʵÄÏ¡ÏõËᣬ¸Ä±äÄòÒºµÄpHΪËáÐÔ£¬½â¾Ûµ°°×-ÒøÀë×ÓòüºÏÎÐγÉÀàËÆÏõËáÒøÖ®ÀàµÄÒ×ÈܽâÐÍÏõËáÑΣ¬½âÀëºóµÄµ°°×»¹¿ÉÒÀ¿¿¿Õ¼äλ×èÀ´×è¶ÏÒøÀë×ÓÓë¹Ü±ÚµÄÔÙÎü¸½£¬»ñµÃÈ«²¿ÓÎÀëÐÍÒøÀë×Ó£»
4£©²ÉÓÃÊʵ±·ÖÀë¼¼Êõ£¬½«´æÔÚÓÚ±¶ÂÊÏ¡ÏõËáÌåϵµÄÓÎÀëÐÍÒøÀë×Ó×ªÒÆµ½µÍÎü¸½ÈÝÆ÷ÖУ¬½øÑù¼ì²â¡£

¡ø “µ°°×Öû»·¨”ÔÀí
·½·¨×¼È·¶ÈºÍ¾«ÃܶÈÑéÖ¤
¶Ô5ÖÖŨ¶ÈÖÊ¿ØÆ·Í¨¹ý2ÌìÁ¬Ðø3Åúǰ´¦Àí£¬½áºÏICP-MSÑéÖ¤±¾·½·¨¼ì²âÄòÒºÖÐÒøÀë×ÓŨ¶ÈµÄ׼ȷ¶È£¨»ØÊÕÂÊ£©ºÍ¾«Ãܶȣ¨Öظ´ÐÔ£©¡£½á¹û±íÃ÷£º5¸ö²»Í¬Å¨¶ÈÒøÖÊ¿ØÆ·£¬¸÷ÖØ¸´²â¶¨6´ÎµÄ׼ȷ¶ÈÆ«²î²»³¬¹ý±êʾֵµÄ-2.61%~5.23%£¬¾ù·ûºÏ±15%Ö®ÄڵĽÓÊܱê×¼£»¸÷Ũ¶ÈϵÄÒøÖÊ¿ØÆ·£¬6´Î²âÁ¿½á¹ûÅúÄÚ¡¢Åú¼ä¾«ÃܶÈCV%ÔÚ0.76%~1.93%£¬¾ù·ûºÏ≤15%µÄ½ÓÊܱê×¼£¬ÑéÖ¤Á˱¾·½·¨µÄ׼ȷ¶ÈºÍ¾«ÃܶȷûºÏPK¶¨Á¿ÒªÇó¡£
С½á
Å·²©¼¯ÍÅÉúÎï·ÖÎö²âÊÔÖÐÐÄÀûÓÃÒøÀë×ÓÔÚpHΪÈõ¼îÐÔ»òÖÐÐÔʱÓëµ°°×µÄ½áºÏÁ¦¸üÇ¿ÓÚÓëÈÝÆ÷¹Ü±ÚµÄ½áºÏÁ¦£¬µ°°×-ÒøÀë×ӵȽðÊôòüºÏÎïÔÚ¼îÐÔϽáºÏ¡¢ÔÚËáÐÔÌõ¼þÏÂÍêÈ«½âÀëµÄÔÀí£¬ÃþË÷³ö“µ°°×Öû»·¨”£¬ÓÐЧ½â¾öÁËÄòÒºÖÐÒøÀë×Ӳⲻ׼£¬ÄÑÖØ¸´µÄÎÊÌ⣬·½·¨ÑéÖ¤ºÏ¸ñ¡£
Ŀǰ£¬Ïà¹Ø·½·¨ÒÑÐγɼ¼ÊõרÀûÇÒÓ¦Óõ½Êµ¼ÊÑù±¾PK¶¨Á¿Ñо¿£¬Í¬Ê±½áºÏÁÙ´²ÊÔÑéÁªÃË¡¢×ÔÖ÷¿ª·¢µÄLIMSÐÅÏ¢»¯ÏµÍ³ºÍÑϽ÷µÄÊý¾Ýͳ¼ÆÍŶӵÈ×ÔÉíÓÅÊÆ×ÊÔ´£¬¸üºÃµÄ·þÎñÓÚÁÙ´²ÆÀ¼Û£¬»¶Ó×ÉѯºÏ×÷¡£
²Î¿¼ÎÄÏ×
[1] Lin YS, Rothen ML, Milgrom P.Pharmacokinetics of 38% topical silver diamine fluoride in healthy adult volunteers [J].J Am Dent Assoc£¬2019,150(3):186-192
[2] ³¤É³Å·²©¼¯ÍÅÉúÎï¿Æ¼¼ÓÐÏÞÔðÈι«Ë¾£¬Ò»ÖÖÉúÎï»ùÖÊÖÐÒøÀë×Ó¸»¼¯·½·¨¡¢¶¨Á¿ÊÔ¼ÁºÐ¼°¼ì²â·½·¨[P],2020105001519
×÷ÕߣººîÀûƽ